Induction of microsomal prostaglandin E synthase-1 in human gingival fibroblasts

Tülay Yucel-Lindberg1, Therese Hallström, Anna Kats

  • 1Department of Pediatric Dentistry, Institute of Odontology, Karolinska Institutet, Box 4064, S-141 04, Huddinge, Sweden. tulay.lindberg@ofa.ki.se

Inflammation
|September 24, 2004
PubMed

Insights

Microsomal prostaglandin E synthase-1 (mPGES-1) regulates prostaglandin E2 (PGE2) production in human gingival fibroblasts stimulated by inflammatory mediators. This pathway offers a potential therapeutic target for periodontal disease treatment.

Area of Science:

  • Immunology
  • Biochemistry
  • Periodontology

Background:

  • Prostaglandin E2 (PGE2) is a key mediator in inflammatory diseases like periodontitis.
  • Interleukin-1beta (IL-1beta) and Tumor Necrosis Factor alpha (TNFalpha) induce PGE2 synthesis via cyclooxygenase-2 (COX-2) in gingival fibroblasts.

Purpose of the Study:

  • To investigate the role of microsomal prostaglandin E synthase-1 (mPGES-1) in PGE2 production.
  • To determine if mPGES-1 is involved in inflammatory mediator-induced PGE2 synthesis in human gingival fibroblasts.

Main Methods:

  • Human gingival fibroblasts were stimulated with IL-1beta and TNFalpha.
  • mRNA and protein expression of mPGES-1 were analyzed.
  • PGE2 production was quantified.
  • Effects of dexamethasone (DEX) and celecoxib were assessed.

Main Results:

  • IL-1beta and TNFalpha significantly increased mPGES-1 mRNA and protein expression, alongside enhanced PGE2 production.
  • Dexamethasone inhibited IL-1beta/TNFalpha-induced mPGES-1 expression and PGE2 production.
  • The COX-2 specific inhibitor, celecoxib, reduced IL-1beta-induced mPGES-1 expression.

Conclusions:

  • mPGES-1 is a critical regulator of PGE2 production in gingival fibroblasts stimulated by inflammatory mediators.
  • The mPGES-1 pathway represents a novel therapeutic target for managing periodontal disease.

Related Concept Videos